These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 10371508

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates.
    Elster EA, Xu H, Tadaki DK, Montgomery S, Burkly LC, Berning JD, Baumgartner RE, Cruzata F, Marx R, Harlan DM, Kirk AD.
    Transplantation; 2001 Nov 15; 72(9):1473-8. PubMed ID: 11707732
    [Abstract] [Full Text] [Related]

  • 3. Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograft recipients.
    Cho CS, Burkly LC, Fechner JH, Kirk AD, Oberley TD, Dong Y, Brunner KG, Peters D, Tenhoor CN, Nadeau K, Yagci G, Ishido N, Schultz JM, Tsuchida M, Hamawy MM, Knechtle SJ.
    Transplantation; 2001 Aug 27; 72(4):587-97. PubMed ID: 11544416
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantation.
    Montgomery SP, Xu H, Tadaki DK, Celniker A, Burkly LC, Berning JD, Cruzata F, Elster EA, Gray G, Kampen RL, Swanson SJ, Harlan DM, Kirk AD.
    Transplantation; 2002 Nov 27; 74(10):1365-9. PubMed ID: 12451232
    [Abstract] [Full Text] [Related]

  • 6. Effects of combined treatment with CD25- and CD154-specific monoclonal antibodies in non-human primate allotransplantation.
    Xu H, Elster EA, Blair PJ, Burkly LC, Tadaki DK, Harlan DM, Kirk AD.
    Am J Transplant; 2003 Nov 27; 3(11):1350-4. PubMed ID: 14525594
    [Abstract] [Full Text] [Related]

  • 7. IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates.
    Preston EH, Xu H, Dhanireddy KK, Pearl JP, Leopardi FV, Starost MF, Hale DA, Kirk AD.
    Am J Transplant; 2005 May 27; 5(5):1032-41. PubMed ID: 15816883
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of ABI793, a novel human anti-human CD154 monoclonal antibody, in cynomolgus monkey renal allotransplantation.
    Schuler W, Bigaud M, Brinkmann V, Di Padova F, Geisse S, Gram H, Hungerford V, Kleuser B, Kristofic C, Menninger K, Tees R, Wieczorek G, Wilt C, Wioland C, Zurini M.
    Transplantation; 2004 Mar 15; 77(5):717-26. PubMed ID: 15021835
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates.
    Kirk AD, Harlan DM, Armstrong NN, Davis TA, Dong Y, Gray GS, Hong X, Thomas D, Fechner JH, Knechtle SJ.
    Proc Natl Acad Sci U S A; 1997 Aug 05; 94(16):8789-94. PubMed ID: 9238056
    [Abstract] [Full Text] [Related]

  • 12. Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates.
    Kirk AD, Tadaki DK, Celniker A, Batty DS, Berning JD, Colonna JO, Cruzata F, Elster EA, Gray GS, Kampen RL, Patterson NB, Szklut P, Swanson J, Xu H, Harlan DM.
    Transplantation; 2001 Aug 15; 72(3):377-84. PubMed ID: 11502964
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prevention of kidney allograft rejection using anti-CD40 and anti-CD86 in primates.
    Haanstra KG, Ringers J, Sick EA, Ramdien-Murli S, Kuhn EM, Boon L, Jonker M.
    Transplantation; 2003 Mar 15; 75(5):637-43. PubMed ID: 12640302
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Anti-C5 Antibody Tesidolumab Reduces Early Antibody-mediated Rejection and Prolongs Survival in Renal Xenotransplantation.
    Adams AB, Lovasik BP, Faber DA, Burlak C, Breeden C, Estrada JL, Reyes LM, Vianna RM, Tector MF, Tector AJ.
    Ann Surg; 2021 Sep 01; 274(3):473-480. PubMed ID: 34238812
    [Abstract] [Full Text] [Related]

  • 19. CD40 expression on graft infiltrates and parenchymal CD154 (CD40L) induction in human chronic renal allograft rejection.
    Gaweco AS, Mitchell BL, Lucas BA, McClatchey KD, Van Thiel DH.
    Kidney Int; 1999 Apr 01; 55(4):1543-52. PubMed ID: 10201021
    [Abstract] [Full Text] [Related]

  • 20. Fc-Silent Anti-CD154 Domain Antibody Effectively Prevents Nonhuman Primate Renal Allograft Rejection.
    Kim SC, Wakwe W, Higginbotham LB, Mathews DV, Breeden CP, Stephenson AC, Jenkins J, Strobert E, Price K, Price L, Kuhn R, Wang H, Yamniuk A, Suchard S, Farris AB, Pearson TC, Larsen CP, Ford ML, Suri A, Nadler S, Adams AB.
    Am J Transplant; 2017 May 01; 17(5):1182-1192. PubMed ID: 28097811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.